Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant,
primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic …
primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic …
Emerging strategies for treating metastasis
The systemic spread of tumor cells is the ultimate cause of the majority of deaths from
cancer, yet few successful therapeutic strategies have emerged to specifically target …
cancer, yet few successful therapeutic strategies have emerged to specifically target …
Lipid peroxidation in brain tumors
There is a lot of evidence showing that lipid peroxidation plays very important role in
development of various diseases, including neurodegenerative diseases and brain tumors …
development of various diseases, including neurodegenerative diseases and brain tumors …
A potential mechanism of temozolomide resistance in glioma–ferroptosis
Z Hu, Y Mi, H Qian, N Guo, A Yan, Y Zhang… - Frontiers in …, 2020 - frontiersin.org
Temozolomide (TMZ) is the first-line chemotherapy drug that has been used to treat glioma
for over a decade, but the benefits are limited by half of the treated patients who acquired …
for over a decade, but the benefits are limited by half of the treated patients who acquired …
CRISPR/Cas9-mediated gene therapy for glioblastoma: a sco** review
This sco** review examines the use of CRISPR/Cas9 gene editing in glioblastoma (GBM),
a predominant and aggressive brain tumor. Categorizing gene targets into distinct groups …
a predominant and aggressive brain tumor. Categorizing gene targets into distinct groups …
Ferroptosis-driven nanotherapeutics to reverse drug resistance in tumor microenvironment
L Zhu, D Meng, X Wang, X Chen - ACS Applied Bio Materials, 2022 - ACS Publications
Ferroptosis, characterized by iron-dependent lipid reactive oxygen species (ROS)
accumulation, is non-apoptotic programmed cell death highly relevant to tumor …
accumulation, is non-apoptotic programmed cell death highly relevant to tumor …
Glioblastoma stem cells—useful tools in the battle against cancer
SMB Rodriguez, GA Staicu, AS Sevastre… - International Journal of …, 2022 - mdpi.com
Glioblastoma stem cells (GSCs) are cells with a self-renewal ability and capacity to initiate
tumors upon serial transplantation that have been linked to tumor cell heterogeneity. Most …
tumors upon serial transplantation that have been linked to tumor cell heterogeneity. Most …
The reactive species interactome in the brain
E Malard, S Valable, M Bernaudin, E Pérès… - Antioxidants & Redox …, 2021 - liebertpub.com
Significance: Redox pioneer Helmut Sies attempted to explain reactive species' challenges
faced by organelles, cells, tissues, and organs via three complementary definitions:(i) …
faced by organelles, cells, tissues, and organs via three complementary definitions:(i) …
Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
S Zhuo, G He, T Chen, X Li, Y Liang, W Wu… - Frontiers in Molecular …, 2022 - frontiersin.org
Glioblastoma (GBM) is the most common malignant craniocerebral tumor. The treatment of
this cancer is difficult due to its high heterogeneity and immunosuppressive …
this cancer is difficult due to its high heterogeneity and immunosuppressive …
The therapeutic potential of aprepitant in glioblastoma cancer cells through redox modification
Although there is no doubt regarding the involvement of oxidative stress in the development
of glioblastoma, many questions remained unanswered about signaling cascades that …
of glioblastoma, many questions remained unanswered about signaling cascades that …